News for EHAVE, Inc. (EHVVF)

MIAMI, March 25, 2025 (GLOBE NEWSWIRE) -- AIBotics ('AIBotics” or the 'Company”) (OTC: AIBT), a subsidiary of Ehave (OTC: EHVVF) that develops and manages AI- and robotics-enhanced technologies, today announced that its flagship product, the Phill Robot™ massager, is expected to become available in the United States in the second quarter.

Agreement Includes Advanced Machine Learning, Computer Vision, and Robotics Solutions, Featuring the Phill Robot Massage App and Website MIAMI, Feb. 18, 2025

MIAMI, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. dba AIBotics (”œAIBotics” or the ”œCompany”) ( TPIA) and a wholly owned subsidiary of

AIBotics and DigiTrax Entertainment aim to redefine music creation and experience using Artificial Intelligence based algorithms trained in music theory, tapping into the $2.9 billion Global AI in Music market

**media[503393]**

First Person Inc is setting up a psychedelic mushroom company in Jamaica for research and development, with an initial outlay of US$500,000. The funds would come from the Canadian company’s pending initial public offering of shares that’s aimed at...

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review. In connection with the preparation of the Ehave, Inc. financial... | May 2, 2023

VANCOUVER, British Columbia, March 01, 2023 (GLOBE NEWSWIRE) -- Birchtree Investments Ltd. (“Birchtree” or the “Company”) (CSE: BRCH), an investment...

Ehave, Inc. (OTC: EHVVF) has completed the first of three planned phases of its studies with the University of Melbourne to determine the cause and possible cure for hallucinogen-persisting perception disorder (HPPD).

Potential of monetizing HPPD research by identifying biomarkers to identify individuals who have a higher risk of developing HPPD if they take...

After a full review of healthcare provider Ehave Inc.'s (OTC Pink: EHVVF) IND application, the U.S.

Share this article MIAMI – Ehave, Inc. (OTC Pink: EHVVF), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will ...

Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.

Mycotopia Therapies (OTCPK:TPIA) subsidiary of Ehave, Inc. (OTCPK:EHVVF), has signed a definitive agreement to complete a triangular merger with Ei.Ventures, to form PSLY.COM. The companies anticipate closing the transaction on or about July 30, 2022.